Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS27A pseudogene 14 is a non-functional duplicate (pseudogene) related to the human ribosomal protein S27a gene (RPS27A). Pseudogenes such as RPS27AP14 arise through gene duplication or retrotransposition and typically do not encode functional proteins. Although the parent gene, RPS27A, is involved in ribosome biogenesis and associated with various biological processes and diseases, the pseudogene itself lacks evidence of protein-coding potential, biological activity, or clinical relevance as a drug target[3][7][10].\n\nNote:\n- RPS27A pseudogene 14 should not be confused with the functional RPS27A gene, which encodes a ribosomal protein involved in essential cellular processes[1][2][6].\n- The only context for RPS27AP14 in scientific databases is as a genomic annotation and not as a functional or therapeutic target.\n\nThis molecule/receptor is not considered a therapeutic target, and there is nothing to indicate disease relevance, drug interactions, or utility as a biomarker[7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S27a pseudogene 14 (RPS27AP14).